\
&
Contact us
This was 1 year ago
LocationOnline
ProgrammesSEREN5 is hosting its next online stakeholder training event entitled, ‘Horizon Europe Security Appraisal Process’ in collaboration with the European Commission’s Department DG HOME.
It forms part of a series of SEREN5 training sessions, which aims to raise the standards of learning and knowledge for its stakeholders, which in turn contributes to improving the quality of Horizon Europe proposals.
Agenda and more details can be found here.
You can register for this training via this webform: https://forms.office.com/e/QXwZuJbwnk
You can also find more information on the security appraisal process in the dedicated infosheet (Security appraisal procedure in Horizon Europe) on our website .
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.